CMS Announces End to Medicare Part B Drug Payment Model
On December 15, 2016, the Centers for Medicare and Medicaid Services (CMS) announced the cancellation of Medicare Part B Drug Payment Model. CMS initially proposed the demonstration on March 8, 2016 to test new models in how physician-administered drugs are paid under the Medicare program.
In May 2016, ASH submitted comments on the proposed rule expressing concern that the demonstration could create barriers to access to important and life-saving drugs. Under the proposal, CMS would have adjusted the payment rate for individual drugs in the hopes to incentivize selection based on performance rather than price. However, ASH stressed that for hematology, there is often no choice in chemotherapeutic agents, and consequently, a change in the payment rate for individual drugs could make providing certain drugs more difficult for physician practices and hospitals.
From the beginning, the proposed model was controversial, and received pushback from medical specialty societies, cancer groups, pharmaceutical companies and hospital organizations, among others. CMS indicated that the cancellation was in large part a result of the 1,300 public comments received, most of which were negative. ASH will continue to support innovation in delivery and payment models to help reduce the burden of the overall cost of medical care and particularly, the high cost of drugs, without compromising access to care.
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission